Market Closed -
Xetra
11:35:03 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
25.77
EUR
|
+0.04%
|
|
-0.31%
|
-9.16%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,231
|
5,419
|
4,701
|
3,255
|
2,450
|
2,225
|
-
|
-
|
Enterprise Value (EV)
1 |
6,973
|
6,431
|
6,946
|
7,069
|
2,450
|
4,795
|
4,628
|
4,435
|
P/E ratio
|
25.8
x
|
6.14
x
|
17.6
x
|
17.7
x
|
5.53
x
|
-11.7
x
|
109
x
|
19.4
x
|
Yield
|
1.59%
|
1.59%
|
1.93%
|
2.79%
|
-
|
0.4%
|
2.01%
|
1.66%
|
Capitalization / Revenue
|
0.73
x
|
0.89
x
|
0.62
x
|
0.4
x
|
0.36
x
|
0.34
x
|
0.32
x
|
0.31
x
|
EV / Revenue
|
0.98
x
|
1.05
x
|
0.92
x
|
0.87
x
|
0.36
x
|
0.73
x
|
0.66
x
|
0.62
x
|
EV / EBITDA
|
6.84
x
|
7.46
x
|
6.88
x
|
7.6
x
|
4.78
x
|
8.52
x
|
6.16
x
|
5.37
x
|
EV / FCF
|
51.7
x
|
49.9
x
|
-174
x
|
-28.5
x
|
-
|
24.5
x
|
23.3
x
|
15.9
x
|
FCF Yield
|
1.94%
|
2.01%
|
-0.58%
|
-3.51%
|
-
|
4.09%
|
4.3%
|
6.3%
|
Price to Book
|
2
x
|
1.83
x
|
1.25
x
|
0.74
x
|
-
|
0.52
x
|
0.52
x
|
0.51
x
|
Nbr of stocks (in thousands)
|
87,448
|
86,346
|
86,258
|
86,346
|
86,346
|
86,346
|
-
|
-
|
Reference price
2 |
59.82
|
62.76
|
54.50
|
37.70
|
28.37
|
25.77
|
25.77
|
25.77
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/11/22
|
3/15/23
|
3/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
7,131
|
6,104
|
7,557
|
8,088
|
6,714
|
6,611
|
6,970
|
7,204
|
EBITDA
1 |
1,019
|
862
|
1,010
|
930
|
512
|
563
|
751.2
|
826.5
|
EBIT
1 |
557
|
396
|
500
|
389
|
-53
|
19.06
|
211.2
|
296.5
|
Operating Margin
|
7.81%
|
6.49%
|
6.62%
|
4.81%
|
-0.79%
|
0.29%
|
3.03%
|
4.12%
|
Earnings before Tax (EBT)
1 |
346
|
1,074
|
303
|
257
|
-947
|
-197.3
|
66.79
|
172.9
|
Net income
1 |
205
|
885
|
267
|
250
|
443
|
-226.4
|
21.99
|
107.7
|
Net margin
|
2.87%
|
14.5%
|
3.53%
|
3.09%
|
6.6%
|
-3.42%
|
0.32%
|
1.5%
|
EPS
2 |
2.320
|
10.22
|
3.090
|
2.130
|
5.130
|
-2.200
|
0.2370
|
1.330
|
Free Cash Flow
1 |
135
|
129
|
-40
|
-248
|
-
|
196
|
199
|
279.3
|
FCF margin
|
1.89%
|
2.11%
|
-0.53%
|
-3.07%
|
-
|
2.96%
|
2.86%
|
3.88%
|
FCF Conversion (EBITDA)
|
13.25%
|
14.97%
|
-
|
-
|
-
|
34.81%
|
26.49%
|
33.8%
|
FCF Conversion (Net income)
|
65.85%
|
14.58%
|
-
|
-
|
-
|
-
|
904.82%
|
259.27%
|
Dividend per Share
2 |
0.9500
|
1.000
|
1.050
|
1.050
|
-
|
0.1022
|
0.5188
|
0.4267
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/11/22
|
3/15/23
|
3/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
3,140
|
1,951
|
2,082
|
2,432
|
1,999
|
3,930
|
2,185
|
1,973
|
1,899
|
1,778
|
1,601
|
1,436
|
1,528
|
1,703
|
1,774
|
1,651
|
1,601
|
EBITDA
1 |
-
|
278
|
213
|
320
|
253
|
515
|
240
|
175
|
189
|
107
|
119
|
97
|
93.74
|
129.7
|
169
|
171.7
|
160.9
|
EBIT
1 |
165
|
146
|
72
|
182
|
122
|
260
|
101
|
28
|
53
|
-29
|
-22
|
-55
|
-35.52
|
-3.675
|
35.47
|
40.55
|
22.22
|
Operating Margin
|
5.25%
|
7.48%
|
3.46%
|
7.48%
|
6.1%
|
6.62%
|
4.62%
|
1.42%
|
2.79%
|
-1.63%
|
-1.37%
|
-3.83%
|
-2.32%
|
-0.22%
|
2%
|
2.46%
|
1.39%
|
Earnings before Tax (EBT)
1 |
-
|
94
|
16
|
-
|
67
|
-
|
120
|
-21
|
13
|
-157
|
-142
|
-661
|
-87
|
-42
|
-25
|
-43
|
-
|
Net income
1 |
-
|
74
|
29
|
98
|
93
|
-
|
80
|
-21
|
-44
|
1,371
|
-131
|
-753
|
-92.5
|
-43
|
-26
|
-44
|
-
|
Net margin
|
-
|
3.79%
|
1.39%
|
4.03%
|
4.65%
|
-
|
3.66%
|
-1.06%
|
-2.32%
|
77.11%
|
-8.18%
|
-52.44%
|
-6.05%
|
-2.52%
|
-1.47%
|
-2.66%
|
-
|
EPS
2 |
9.930
|
0.8600
|
0.3400
|
1.130
|
1.080
|
2.210
|
0.9300
|
-0.1600
|
-0.5100
|
15.88
|
-1.520
|
-8.720
|
-1.120
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
1.050
|
-
|
-
|
-
|
-
|
1.050
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1200
|
-
|
Announcement Date
|
8/13/20
|
11/4/21
|
3/11/22
|
5/5/22
|
8/4/22
|
8/4/22
|
11/9/22
|
3/15/23
|
5/10/23
|
8/4/23
|
11/8/23
|
3/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,742
|
1,012
|
2,245
|
3,814
|
-
|
2,569
|
2,402
|
2,209
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.71
x
|
1.174
x
|
2.223
x
|
4.101
x
|
-
|
4.564
x
|
3.198
x
|
2.673
x
|
Free Cash Flow
1 |
135
|
129
|
-40
|
-248
|
-
|
196
|
199
|
279
|
ROE (net income / shareholders' equity)
|
7.52%
|
31.2%
|
7.9%
|
6.11%
|
-
|
-2.52%
|
2.77%
|
4.83%
|
ROA (Net income/ Total Assets)
|
2.36%
|
10.1%
|
2.75%
|
2.29%
|
-
|
-2.07%
|
0.05%
|
1.22%
|
Assets
1 |
8,691
|
8,788
|
9,699
|
10,905
|
-
|
10,913
|
44,084
|
8,816
|
Book Value Per Share
2 |
30.00
|
34.30
|
43.50
|
51.20
|
-
|
49.40
|
49.40
|
50.50
|
Cash Flow per Share
2 |
7.280
|
6.760
|
4.710
|
1.350
|
-
|
4.790
|
5.650
|
5.260
|
Capex
1 |
508
|
456
|
479
|
407
|
-
|
349
|
378
|
395
|
Capex / Sales
|
7.12%
|
7.47%
|
6.34%
|
5.03%
|
-
|
5.28%
|
5.42%
|
5.48%
|
Announcement Date
|
3/11/20
|
3/11/21
|
3/11/22
|
3/15/23
|
3/14/24
|
-
|
-
|
-
|
Last Close Price
25.77
EUR Average target price
28.15
EUR Spread / Average Target +9.23% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.16% | 2.38B | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B | | +3.85% | 8.11B |
Diversified Chemicals
|